Search
Stryker Corp
SYKAdd to Watchlist
304.680USD
-3.120-1.01%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
116.81BMarket Cap
34.92P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-1.01%
5 Days
-1.06%
1 Month
-3.73%
6 Months
-14.54%
Year to Date
-13.31%
1 Year
-18.87%
Key Figures
307.560Open
311.820High
2.40MVolume
34.92P/E TTM
18.02P/E Dynamic
3.440Dividend TTM
0.62%Turnover Ratio
307.800Prev. Close
303.590Low
411.19MTurnover
39.03P/E Static
5.08P/B
1.13%Div Yield TTM
7.23%ROA
404.87052wk High
0.87Volume Ratio
2.99BNet Profit
383.40MShares
8.7252EPS TTM
0.79Beta
15.20%ROE
281.00052wk Low
2.67%Amplitude
60.58%Gross Margin
116.81BMarket Cap
-1.42Reward/Risk
1.28%Risk Rate
TradingKey Stock Score of Stryker Corp
Currency: USD Updated: 2026-06-22Key Insights
Stryker Corp's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 9 out of 203 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 387.27.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Stryker Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
29°C
Very Low
Very High
Negative
Stryker Corp Highlights
StrengthsRisks
Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 22.53% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 41.30%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 41.30%.
Undervalued
The company’s latest PE is 34.92, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 312.34M shares, decreasing 1.14% quarter-over-quarter.
Held by Jerome Dodson | PARNX
Star Investor Jerome Dodson | PARNX holds 2.19M shares of this stock.
Analyst Rating
Based on
31
analysts
Buy
Current Rating
387.267
Target Price
+25.82%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Stryker Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Stryker Corp Info
Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
Ticker SymbolSYK
CompanyStryker Corp
CEOLobo (Kevin A)
Websitehttps://www.stryker.com/
Related Instruments
+1.42%
-0.07%
-0.72%
-0.96%
+3.03%
+0.63%
-0.09%
+1.65%
+0.45%
+0.98%
-2.15%
-0.17%
-1.69%
-3.42%
+0.07%
-2.91%
-2.27%
-0.46%
+0.77%Popular Instruments
73.845
-0.144 (-0.20%)
297.230
-0.780 (-0.26%)
208.780
-1.910 (-0.91%)
4126.800
-63.450 (-1.51%)
732.810
-13.420 (-1.80%)
2273.370
+88.620 (+4.06%)
1213.000
+79.010 (+6.97%)
349.710
-18.320 (-4.98%)
62570.010
-1833.790 (-2.85%)
404.920
+4.430 (+1.11%)
FAQs
What is the current price of Stryker Corp (SYK)?
The current price of Stryker Corp (SYK) is 304.68.
What is the symbol of Stryker Corp?
The ticker symbol of Stryker Corp is SYK.
What is the 52-week high of Stryker Corp?
The 52-week high of Stryker Corp is 404.87.
What is the 52-week low of Stryker Corp?
The 52-week low of Stryker Corp is 281.00.
What is the market capitalization of Stryker Corp?
The market capitalization of Stryker Corp is 116.81B.
Is Stryker Corp (SYK) currently rated as Buy, Hold, or Sell?
According to analysts, Stryker Corp (SYK) has an overall rating of Buy, with a price target of 387.27.
What is the Earnings Per Share (EPS TTM) of Stryker Corp (SYK)?
The Earnings Per Share (EPS TTM) of Stryker Corp (SYK) is 8.49.
